NCT01235949 Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A and Prophylactic Antipyretic Treatment Status COMPLETED Phase PHASE4
NCT01231620 A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza Status COMPLETED Phase PHASE3
NCT01231607 Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia Status COMPLETED Phase PHASE3
NCT01231581 Study of GSK1120212 Plus Gemcitabine vs Placebo Plus Gemcitabine in Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT01231568 An Open Label Study to Examine the Effects of a High-Fat Meal and Particle Size on the Pharmacokinetics of Orally Administered GSK2118436 in Subjects With BRAF Mutation Positive Tumor Status COMPLETED Phase PHASE1
NCT01231555 Dose-finding Study of GSK2248761 in Antiretroviral Therapy-Naive Subjects (SIGNET) Status TERMINATED Phase PHASE2
NCT01231542 Phase 1, Open Label, Two Arm, Fixed Sequence Study to Evaluate the Effect of Rifampin and Rifabutin on GSK1349572 Pharmacokinetics in Healthy Male and Female Volunteers Status COMPLETED Phase PHASE1
NCT01231516 A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults Status COMPLETED Phase PHASE3
NCT01231503 Safety and Immunogenicity of GSK Biologicals' Malaria Vaccine 257049 When Administered on 7 Schedules to African Infants Status COMPLETED Phase PHASE2
NCT01231464 A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fluticasone Furoate Nasal Spray for 2 Weeks in Chinese Adult and Adolescent Subjects With Allergic Rhinitis Status COMPLETED Phase PHASE3
NCT01231230 Interactive Acute Smooth Muscle Effects of Salmeterol and Fluticasone in the Airway Status COMPLETED Phase NA
NCT01227928 Efficacy and Safety of Pazopanib Monotherapy After First-line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Asian Women Status COMPLETED Phase PHASE2
NCT01227902 Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures Status COMPLETED Phase PHASE3
NCT01227889 A Study Comparing GSK2118436 to Dacarbazine (DTIC) in Previously Untreated Subjects With BRAF Mutation Positive Advanced (Stage III) or Metastatic (Stage IV) Melanoma Status COMPLETED Phase PHASE3
NCT01227824 A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily Status COMPLETED Phase PHASE3
NCT01227369 Quality of Life(QoL) in Korean Postmenopausal Osteoporosis Patients With Bisphosphonate Treatment Status COMPLETED Phase N/A
NCT01224821 Dosimetry/Validation Study of 131Iodine-Anti B1 (Murine) Radioimmunotherapy for Chemotherapy Refractory Low Grade B Cell Lymphomas and Low Grade Lymphomas That Have Transformed to Higher Grade Histologies Status COMPLETED Phase PHASE2
NCT01222078 Investigating Re-Dosing With Otelixizumab in Adults With Newly-Diagnosed Type 1 Diabetes Mellitus Status TERMINATED Phase PHASE2